Wockhardt informs about outcome of board meeting

09 Aug 2024 Evaluate

Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations’); and in continuation to its letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/032 dated 5th August, 2024, Wockhardt has informed that the Board of Directors of the Company, at its meeting held today 9th August, 2024, have approved: 1. The Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2024. Pursuant to Regulations 30 and 33 of Listing Regulations read with Para A of Part A of Schedule III of Listing Regulations, it has enclosed the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2024 along with the Limited Review Report thereon issued by M S K C & Associates., Statutory Auditors of the Company as Annexure I. 2. Appointment of Paresh Kajrolkar, Head of Internal Audit, based on recommendations of Audit Committee, as Internal Auditor of the Company with effect from 9th August, 2024. The details required to be furnished pursuant under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure-II. The meeting of the Board of Directors commenced at 12:20 pm and concluded at 2:50 pm.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1230.95 58.60 (5.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.